Lv31
254 积分 2023-12-24 加入
Building an oral peptide drug
3小时前
待确认
Evaluating generalization in protein-ligand cofolding methods
1个月前
已关闭
Pamrevlumab, an anti-connective tissue growth factor therapy, for idiopathic pulmonary fibrosis (PRAISE): a phase 2, randomised, double-blind, placebo-controlled trial
1个月前
已完结
Progressive Pulmonary Fibrosis Is Caused by Elevated Mechanical Tension on Alveolar Stem Cells
1个月前
已完结
An Antibody–Oligonucleotide Conjugate for Myotonic Dystrophy Type 1
2个月前
已完结
Now with oligos: antibody–oligonucleotide conjugates are the new drug modality to watch
2个月前
已完结
An Antibody–Oligonucleotide Conjugate for Myotonic Dystrophy Type 1
2个月前
已完结
Solute carrier inhibitors in kidney disease therapy: mechanisms and clinical implications
2个月前
已完结
Taking charge of siRNA delivery
2个月前
已完结
Enhancing siRNA efficacy in vivo with extended nucleic acid backbones
2个月前
已完结
皖公网安备34019202002308
